omeprazole has been researched along with pentagastrin in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 29 (31.52) | 18.7374 |
1990's | 40 (43.48) | 18.2507 |
2000's | 18 (19.57) | 29.6817 |
2010's | 5 (5.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Cederberg, C; Lind, T; Olbe, L; Röhss, K | 1 |
Bailey, J; Droppleman, D; Forte, JG; Pinkus, LM; Reenstra, WW; Sancilio, LF; Smith, WL | 1 |
Bliesath, H; Hartmann, M; Lühmann, R; Müller, P; Schneider, A; Simon, B; Wurst, W | 1 |
Mezey, E; Potter, JJ; Rennie, L; Sharma, S | 1 |
Fujimoto, M; Fujisaki, H; Murakami, M; Oketani, K; Sakai, H; Shibata, H; Takeguchi, N; Wakabayashi, T; Yamaguchi, M; Yamatsu, I | 1 |
Read, M; Shulkes, A | 1 |
Baron, JH; Gompertz, RH; Li, SK; Man, WK; Michalowski, AS; Spencer, J | 1 |
Harmon, PA; Rutten, MJ | 1 |
Bräuer, U; Kromer, W; Postius, S | 1 |
Bridger, S; Johnston, DA; Marks, IN; Tigler-Wybrandi, NA; Young, GO; Zak, J | 1 |
Cohen, AF; Hoogkamer, H; Kroon, R; Schoemaker, R; van Vliet, A | 1 |
Inatomi, N; Nagaya, H; Satoh, H | 1 |
Bliesath, H; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W | 1 |
Fändriks, L; Gislason, H; Grønbech, JE; Guttu, K; Røsok, B; Svanes, K | 1 |
Ghelani, A; Radziwonik, H | 1 |
Hartmann, R; Huber, R; Lühmann, R; Marinis, E; Müller, P; Simon, B; Wurst, W | 1 |
Eckersall, PD; McKellar, QA; Mostofa, M | 1 |
Bliesath, H; Bohnenkamp, W; Hartmann, M; Huber, R; Lühmann, R; Müller, P; Simon, B; Wurst, W | 1 |
Flemström, G; Holm, L | 1 |
Black, JW; Shankley, NP | 1 |
Kleveland, PM; Sandvik, AK; Waldum, HL | 1 |
Dammann, HG; Leucht, U; Müller, P; Simon, B | 1 |
Den Hollander, W; Festen, HP; Meuwissen, SG; Tuynman, HA | 1 |
Biemond, I; Crobach, LF; Jansen, JB; Lamers, CB | 1 |
De Graef, J; Woussen-Colle, MC | 1 |
Chick, P; Hardy, KJ; Shulkes, A | 1 |
Carlsson, E; Ives, MM; Jensen, NF; Larsen, KR; Larsson, H | 1 |
Festen, HP; Meuwissen, SG; Pals, G; Ten Kate, RW; Tuynman, HA | 1 |
Hansson, HA; Helander, HF; Holmgren, A; Rozell, B | 1 |
Poulsen, SS; Skov Olsen, P; Therkelsen, K | 1 |
Baak, LC; Greve, J; Jansen, JB; Lamers, CB; Lundborg, P; Ohman, M; Röhss, K; Stöver, C | 1 |
Crobach, LF; Jansen, JB; Lamers, CB | 1 |
Guth, PH; Leung, FW; Livingston, E; Pique, JM; Scremin, OU; Tan, HW | 1 |
Cederberg, C; Ekenved, G; Lind, T; Olbe, L | 2 |
Larsson, H; Mattsson, H | 1 |
Cho, CH; Ogle, CW; Wong, SH | 1 |
Bonnevie, O; Nielsen, AM; Stenderup, J; Wandall, JH | 1 |
Baron, JH; Barr, JA; Bush, A; Collier, N; Cope, L; Gribble, RJ; Spencer, J; Thompson, JN | 1 |
Cederberg, C; Ekenved, G; Elander, B; Fellenius, E; Haglund, U; Leth, R; Lind, T; Lundborg, P; Olbe, L; Wallmark, B | 1 |
Dammann, HG; Müller, P; Seitz, HK; Simon, B | 2 |
Konturek, SJ; Kopp, B; Kweicień, N; Obtułowicz, W; Oleksy, J | 1 |
Forrest, JA; Howden, CW; Reid, JL | 1 |
Boyd, EJ; Wilson, JA; Wormsley, KG | 1 |
Bilski, J; Cieszkowski, M; Konturek, J; Konturek, SJ; Kwiecień, N; Tasler, J | 1 |
Larson, GM; Sullivan, HW | 1 |
Cederberg, C; Ekenved, G; Haglund, U; Lind, T; Olbe, L | 1 |
Inaguma, K; Ito, M; Segami, T; Suzuki, Y | 1 |
Bauerfeind, P; Christ, AD; Drewe, J; Gyr, K; Meier, R; Sarker, S | 1 |
Flemström, G; Holm, L; Schade, C | 1 |
Kato, S; Okabe, S; Takeuchi, K | 1 |
Hirschowitz, BI; Mohnen, J; Shaw, S | 1 |
Burrow, JA; Horbal, MJ; Madison, JB; Merritt, AM; Tran, T | 1 |
Arnestad, JS; Brenna, E; Eide, I; Sandvik, AK; Syversen, U; Waldum, HL | 1 |
Başkal, N; Erdoğan, G; Erdoğan, MF; Güllü, S; Kamel, N; Uysal, AR | 1 |
Holm, L; Synnerstad, I | 1 |
Hirata, T; Kato, S; Takeuchi, K | 1 |
Holm, L; Persson, AE; Synnerstad, I | 1 |
Alam, NH; Bardhan, PK; Fuchs, GJ; Gyr, K; Hassan, M; Islam, S; Kiber, A; Mahalanabis, D; Rabbani, KS; Sarker, SA | 1 |
Hardy, KJ; McDowell, GH; Shulkes, A; Westbrook, SL | 1 |
Eberle, C; Feurle, GE; Hamscher, G; Ikonomou, S; Partoulas, G; Sauerbruch, T; Stoschus, B | 1 |
Akiba, Y; Kaunitz, JD; Tanaka, S | 1 |
Arai, H; Inoie, M; Marubuchi, S | 1 |
Grabau, BJ; Hardy, KJ; Shulkes, A; Zavros, Y | 1 |
Impicciatore, M; Letari, O; Makovec, F; Mennuni, L; Revel, L | 1 |
Andrews, FM; Blackford, JT; Doherty, TJ; Nadeau, JA; Saxton, AM | 1 |
Martin, P; McKeand, W; Ohning, G; Paul, J; Pisegna, JR; Walsh, JH | 1 |
Andrews, FM; Blackford, JT; Daurio, CP; Dolz, F; Holste, JE; Merritt, AM; Thompson, DR | 1 |
Angioï, K; Duprez, A; Lozniewski, A; Morali, A; Muhale, F | 1 |
Fuchs, W; Göksu, MA; Müller, P; Schlüter, F; Simon, B | 1 |
Holm, L; Johansson, M; Synnerstad, I | 1 |
Bell, N; Greski-Rose, P; Hunt, RH; Jennings, DE; Karol, MD; Sachs, G | 1 |
Chae, JB; Cho, KD; Huh, IH; Kim, DY; Kim, EJ; Kim, YS; Kwon, D; Lee, SM; Park, CW | 1 |
Brinkmann, A; Eberhardt, H; Geldner, G; Georgieff, M; Glasbrenner, B; Radermacher, P; Vlatten, A; Wiedeck, H | 1 |
Chu, S; Coskun, T; Montrose, MH | 1 |
Andersson, T; Bredberg, E; Hassan-Alin, M; Röhss, K | 1 |
Barontini, M; de, M; Domene, HM; Elsner, B; Garcia, R; Iorcansky, S; Perinetti, H; Pusiol, E; Ring, A; Roque, M; Sanso, GE | 1 |
Bochenek, WJ; Ferron, GM; Metz, DC; Paul, J; Pisegna, JR; Soffer, E; Turner, MB | 1 |
Abbruzzese, A; Caraglia, M; Ciccarelli, A; Del Prete, S; Galderisi, M; Lupoli, G; Rossi, R; Vitale, G | 1 |
Baumgartner, HK; Chu, S; Coskun, T; Montrose, MH | 1 |
Dent, J | 1 |
Fossmark, R; Johanessen, E; Johnsen, G; Waldum, HL | 1 |
Burton, MS; Hogan, DL; Karlstadt, RG; Lane, JR; Lynn, RB; Pratha, VS; Williams, PJ | 1 |
Bytzer, P; Madsen, LG | 1 |
Campbell, CA; Chiu, P; Darton, J; Gaskin, PJ; Lee, K; McLean, PG | 1 |
Anginoni, M; Baggio, CH; Finau, J; Freitas, CS; Marques, MC; Pizzolatti, MG; Santos, AR | 1 |
Abrahamsson, B; Albery, T; Dressman, J; Polentarutti, B | 1 |
Akamatsu, S; Inada, M; Kunizaki, J; Sato, H; Tobita, K | 1 |
Andries, L; Barrett, TD; Freedman, JM; Lagaud, G; Morton, MF; Rizzolio, MC; Shankley, NP; Wagaman, P; Yan, W | 1 |
2 review(s) available for omeprazole and pentagastrin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Review article: pharmacology of esomeprazole and comparisons with omeprazole.
Topics: Anti-Ulcer Agents; Esomeprazole; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Omeprazole; Pentagastrin; Proton Pump Inhibitors | 2003 |
21 trial(s) available for omeprazole and pentagastrin
Article | Year |
---|---|
Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients.
Topics: Administration, Oral; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Duodenal Ulcer; Female; Gastric Acid; Humans; Injections, Intravenous; Male; Omeprazole; Pentagastrin; Time Factors | 1992 |
Reduction of pentagastrin stimulated acid output: a suitable method to predict efficacy of an irreversible proton pump inhibitor in peptic ulcer disease?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Gastric Acid; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Proton Pumps; Single-Blind Method; Sulfoxides | 1992 |
Acid secretory responses and parietal cell sensitivity following duodenal ulcer healing with omeprazole, sucralfate, and Maalox.
Topics: Adult; Aged; Aluminum Hydroxide; Antacids; Drug Combinations; Duodenal Ulcer; Endoscopy, Gastrointestinal; Fasting; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Recurrence; Sucralfate; Wound Healing | 1991 |
Influence of gastric acidity on the bioavailability of digoxin.
Topics: Adult; Biological Availability; Chromatography, High Pressure Liquid; Digoxin; Double-Blind Method; Gastric Acid; Humans; Immunoenzyme Techniques; Male; Omeprazole; Pentagastrin; Random Allocation | 1991 |
Effect of repeated oral administration of BY 1023/SK&F 96022--a new substituted benzimidazole derivative--on pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Blood Pressure; Gastric Acid; Gastrins; Half-Life; Heart Rate; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Sulfoxides | 1990 |
Reduction of gastric acid secretion by 10 mg and 30 mg omeprazole once daily.
Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Pentagastrin; Random Allocation | 1985 |
[Behavior of acid secretion under the long-term daily administration of omeprazol].
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Depression, Chemical; Double-Blind Method; Gastric Acid; Humans; Male; Omeprazole; Pentagastrin; Tablets, Enteric-Coated | 1983 |
Assessment of gastric acid output by H2 breath test.
Topics: Adult; Breath Tests; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen; In Vitro Techniques; Intubation, Gastrointestinal; Magnesium; Male; Omeprazole; Pentagastrin | 1994 |
Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Dropouts; Pentagastrin; Proton Pump Inhibitors; Zollinger-Ellison Syndrome | 1996 |
Marked increase in gastric acid secretory capacity after omeprazole treatment.
Topics: Adult; Aged; Anti-Ulcer Agents; Chromogranin A; Chromogranins; Enterochromaffin Cells; Esophagitis, Peptic; Gastric Acid; Gastric Mucosa; Humans; Hyperplasia; Male; Middle Aged; Omeprazole; Pentagastrin; Proton Pump Inhibitors | 1996 |
Effect of omeprazole treatment on plasma concentrations of the gastric peptides, xenin, gastrin and somatostatin, and of pepsinogen.
Topics: Adult; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Male; Neurotensin; Omeprazole; Pentagastrin; Pepsinogen A; Peptides; Somatostatin | 1998 |
Inhibition of pentagastrin-induced gastric acid secretion by intravenous pantoprazole: a dose-response study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Proton Pump Inhibitors; Sulfoxides; Zollinger-Ellison Syndrome | 1999 |
Effect of omeprazole paste on gastric acid secretion in horses.
Topics: Administration, Oral; Animals; Area Under Curve; Cross-Over Studies; Enzyme Inhibitors; Female; Florida; Gastric Acid; Gastrointestinal Agents; Horses; Intubation, Gastrointestinal; Male; New Jersey; Ointments; Omeprazole; Pentagastrin; Proton Pump Inhibitors; Tennessee | 1999 |
Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Gastric Acid; Gastric Mucosa; Humans; Lansoprazole; Male; Omeprazole; Pentagastrin; Proton Pump Inhibitors; Tablets | 2000 |
Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Double-Blind Method; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pentagastrin; Time Factors | 2001 |
Does gastric juice pH influence tonometric PCO2 measured by automated air tonometry?
Topics: Adult; Automation; Carbon Dioxide; Enzyme Inhibitors; Female; Gastric Juice; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Logistic Models; Male; Manometry; Omeprazole; Partial Pressure; Pentagastrin; Reproducibility of Results | 2001 |
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Area Under Curve; Cross-Over Studies; Esomeprazole; Gastric Acid; Gastric Acidity Determination; Gastrointestinal Agents; Humans; Male; Omeprazole; Pentagastrin; Proton Pump Inhibitors; Proton Pumps; Stereoisomerism; Time Factors | 2001 |
Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Female; Gastric Acid; Humans; Male; Omeprazole; Pantoprazole; Parietal Cells, Gastric; Pentagastrin; Proton Pumps; Sulfoxides; Time Factors | 2002 |
Comparison of two provocative tests for calcitonin in medullary thyroid carcinoma: omeprazole vs pentagastrin.
Topics: Adolescent; Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma; Female; Humans; Male; Middle Aged; Omeprazole; Pentagastrin; Thyroid Neoplasms | 2002 |
Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pantoprazole; Pentagastrin; Prospective Studies; Proton Pump Inhibitors; Reference Values; Stomach; Sulfoxides | 2006 |
Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
Topics: Area Under Curve; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pain Measurement; Pentagastrin; Pilot Projects; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2008 |
69 other study(ies) available for omeprazole and pentagastrin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
Topics: Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Carbachol; Dogs; Female; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine Antagonists; Kinetics; Male; Omeprazole; Pentagastrin; Quinolines; Rats; Rats, Inbred Strains; Swine | 1992 |
Sex differences in gastric alcohol dehydrogenase activity in Sprague-Dawley rats.
Topics: Alcohol Dehydrogenase; Animals; Fasting; Female; Gastric Mucosa; Male; Omeprazole; Pentagastrin; Rats; Rats, Sprague-Dawley; Sex Factors | 1992 |
Inhibitions of acid secretion by E3810 and omeprazole, and their reversal by glutathione.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Aminopyrine; Animals; Benzimidazoles; Bucladesine; Dogs; Dose-Response Relationship, Drug; Gastric Mucosa; Glutathione; H(+)-K(+)-Exchanging ATPase; Histamine; Male; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Rabbits; Rabeprazole; Rana catesbeiana | 1991 |
Regulation of somatostatin secretion by gastrin- and acid-dependent mechanisms.
Topics: Animals; Chromatography, High Pressure Liquid; Female; Gastric Acid; Gastrins; Infusions, Intravenous; Jugular Veins; Omeprazole; Pentagastrin; Portal Vein; Sheep; Somatostatin | 1991 |
Effect of acid blockade on gastric histamine in mice.
Topics: Animals; Female; Gastric Acid; Gastric Mucosa; Histamine; Histamine Release; Mice; Mice, Inbred Strains; Omeprazole; Pentagastrin; Stomach; Vagotomy | 1990 |
Gastric fundic mucous epithelial cells isolated from omeprazole-treated guinea pigs have increased basal and hormone-stimulated growth rates.
Topics: Animals; Basal Metabolism; Cell Count; Cell Division; Cell Separation; Cells, Cultured; Epidermal Growth Factor; Female; Gastric Fundus; Gastric Mucosa; Gastrins; Gastrointestinal Hormones; Guinea Pigs; Omeprazole; Organ Size; Pentagastrin | 1991 |
The novel proton pump inhibitor pantoprazole elevates intragastric pH for a prolonged period when administered under conditions of stimulated gastric acid secretion in the gastric fistula dog.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Famotidine; Gastric Acid; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Pantoprazole; Pentagastrin; Stomach; Sulfoxides | 1991 |
Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Bethanechol Compounds; Dogs; Famotidine; Female; Gastric Acid; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin; Peptones; Pylorus; Rats; Rats, Inbred Strains | 1991 |
Single intravenous administration of the H+, K(+)-ATPase inhibitor BY 1023/SK&F 96022--inhibition of pentagastrin-stimulated gastric acid secretion and pharmacokinetics in man.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Benzimidazoles; Dose-Response Relationship, Drug; Electrocardiography; Gastric Acid; Gastric Juice; H(+)-K(+)-Exchanging ATPase; Half-Life; Humans; Injections, Intravenous; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sulfoxides | 1990 |
Gastric bicarbonate secretion, acid secretion, and mucosal blood flow during influence of pentagastrin and omeprazole in the cat.
Topics: Animals; Bicarbonates; Cats; Gastric Acid; Gastric Mucosa; Omeprazole; Pentagastrin | 1991 |
Use of a cannula insert in erratic emptying Heidenhain pouch dogs: effect of single and cumulative doses of omeprazole.
Topics: Animals; Catheterization; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Female; Gastric Emptying; Gastric Mucosa; Histamine; Hydrogen-Ion Concentration; Infusions, Intravenous; Omeprazole; Pentagastrin | 1990 |
Effect of Ostertagia ostertagi secretions and various putative secretagogues and inhibitors on aminopyrine accumulation in dispersed bovine abomasal gland cells.
Topics: Abomasum; Aminopyrine; Animals; Bucladesine; Cattle; Cell Survival; Cells, Cultured; Cimetidine; Gastric Mucosa; Omeprazole; Ostertagia; Pentagastrin; Thiocyanates | 1990 |
Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Pantoprazole; Pentagastrin; Single-Blind Method; Sodium-Potassium-Exchanging ATPase; Sulfoxides | 1990 |
Microscopy of acid transport at the gastric surface in vivo.
Topics: Acridine Orange; Animals; Biological Transport; Congo Red; Gastric Acid; Gastric Mucosa; Male; Microscopy; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains | 1990 |
The isolated stomach preparation of the mouse: a physiological unit for pharmacological analysis.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Atropine Derivatives; Benzimidazoles; Cimetidine; Fasting; Gastric Acid; Gastric Mucosa; Histamine; Histamine H2 Antagonists; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Mice; Muscarine; Omeprazole; Pentagastrin; Pressure; Tetrodotoxin; Thiocyanates | 1985 |
Stimulated pepsin secretion after omeprazole-induced acid suppression in the totally isolated, vascularly perfused rat stomach.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Gastric Acid; Gastrins; Imidazoles; Impromidine; Male; Omeprazole; Pentagastrin; Pepsin A; Perfusion; Rats; Rats, Inbred Strains; Stomach | 1987 |
Human gastric acid secretion following repeated doses of AG-1749.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Pentagastrin | 1989 |
Repeated high oral doses of omeprazole do not affect intrinsic factor secretion: proof of a selective mode of action.
Topics: Achlorhydria; Gastric Acid; Humans; Intrinsic Factor; Male; Omeprazole; Pentagastrin; Perfusion; Phenolsulfonphthalein | 1989 |
Effect of short-term omeprazole administration on serum pepsinogens in relation to fasting serum gastrin and gastric acid secretion.
Topics: Adult; Fasting; Gastric Acid; Gastrins; Humans; Male; Omeprazole; Pentagastrin; Pepsinogens | 1989 |
Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Dogs; Drug Interactions; Gastric Acid; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Somatostatin | 1986 |
Nature of the gastric acid-gastrin feedback loop in the fetal sheep.
Topics: Animals; Feedback; Female; Fetus; Gastric Acid; Gastric Acidity Determination; Gastrins; Omeprazole; Pentagastrin; Sheep; Somatostatin | 1987 |
Omeprazole and cimetidine versus pentagastrin in canine ex vivo gastric chamber.
Topics: Animals; Cimetidine; Dogs; Female; Gastric Acid; Gastric Juice; Gastric Mucosa; Male; Omeprazole; Oxygen Consumption; Pentagastrin; Potassium; Reference Values; Regional Blood Flow; Sodium; Vascular Resistance | 1989 |
Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.
Topics: Administration, Oral; Adult; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Infusions, Intravenous; Male; Omeprazole; Pentagastrin; Pepsin A; Pepsinogens | 1988 |
Thioredoxin and thioredoxin reductase show function-related changes in the gastric mucosa: immunohistochemical evidence.
Topics: Animals; Atropine; Bacterial Proteins; Carbachol; Gastric Acid; Gastric Mucosa; Immunohistochemistry; Male; NADH, NADPH Oxidoreductases; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains; Thioredoxin-Disulfide Reductase; Thioredoxins; Vagotomy | 1988 |
Effect of omeprazole and cimetidine on healing of chronic gastric ulcers and gastric acid secretion in rats.
Topics: Animals; Cimetidine; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains; Reference Values; Stomach Ulcer | 1988 |
Effect of single and repeated intravenous doses of omeprazole on pentagastrin stimulated gastric acid secretion and pharmacokinetics in man.
Topics: Adult; Gastric Acid; Half-Life; Humans; Injections, Intravenous; Male; Omeprazole; Pentagastrin; Time Factors | 1988 |
Effect of intermittent weekend therapy with omeprazole on basal and bombesin- and pentagastrin-stimulated gastric acid and serum gastrin.
Topics: Adult; Bombesin; Drug Administration Schedule; Gastric Acid; Gastrins; Humans; Male; Omeprazole; Pentagastrin; Time Factors | 1988 |
Gastric mucosal blood flow response to stimulation and inhibition of gastric acid secretion.
Topics: Animals; Cimetidine; Dose-Response Relationship, Drug; Gastric Acid; Gastric Mucosa; Hydrogen; Male; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains; Regional Blood Flow; Stimulation, Chemical | 1988 |
Effect of omeprazole on gastric acid secretion in man.
Topics: Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Gastric Acid; Gastrins; Humans; Omeprazole; Pentagastrin | 1986 |
Effects of omeprazole on gastric mucosal blood flow in the conscious rat.
Topics: Administration, Oral; Animals; Cimetidine; Gastric Acid; Gastric Mucosa; Injections, Intravenous; Male; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains; Regional Blood Flow | 1987 |
The influence of omeprazole on the protective effects of secretagogues against ethanol-induced gastric ulceration in rats.
Topics: Animals; Ethanol; Gastric Mucosa; Histamine; Male; Methacholine Compounds; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains; Stomach Ulcer | 1987 |
Acid inhibitory characteristics of omeprazole in man.
Topics: Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Gastric Acid; Humans; Male; Omeprazole; Pentagastrin | 1985 |
Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Duodenogastric Reflux; Electrolytes; Feeding Behavior; Female; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Pentagastrin; Pepsin A; Potassium | 1985 |
Effects of substituted benzimidazole (H 149/94) on gastric acid secretion in humans.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Benzimidazoles; Bucladesine; Dose-Response Relationship, Drug; Gastric Acid; Histamine; Humans; In Vitro Techniques; Middle Aged; Omeprazole; Pentagastrin; Phosphates | 1982 |
Action of omeprazole (a benzimidazole derivative) on secretory responses to sham feeding and pentagastrin and upon serum gastrin and pancreatic polypeptide in duodenal ulcer patients.
Topics: Adult; Benzimidazoles; Dose-Response Relationship, Drug; Duodenal Ulcer; Eating; Gastric Acid; Gastrins; Humans; Intestinal Secretions; Male; Omeprazole; Pancreatic Polypeptide; Pentagastrin; Pepsin A; Stomach | 1984 |
Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Dose-Response Relationship, Drug; Gastric Acid; Humans; Male; Omeprazole; Pentagastrin; Pepsin A; Secretory Rate | 1984 |
Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Circadian Rhythm; Gastric Acid; Humans; Male; Omeprazole; Pentagastrin; Pepsin A | 1984 |
[Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Gastric Acid; Humans; Kinetics; Male; Omeprazole; Pentagastrin | 1983 |
Effects of omeprazole, a substituted benzimidazole, on gastrointestinal secretions, serum gastrin, and gastric mucosal blood flow in dogs.
Topics: Administration, Topical; Animals; Benzimidazoles; Bethanechol Compounds; Dogs; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Intestinal Secretions; Omeprazole; Pentagastrin; Regional Blood Flow | 1984 |
Omeprazole, a long-lasting inhibitor of gastric secretion.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Dogs; Dose-Response Relationship, Drug; Gastric Acid; Kinetics; Omeprazole; Pentagastrin | 1984 |
Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
Topics: Adult; Benzimidazoles; Dose-Response Relationship, Drug; Gastric Acid; Gastric Acidity Determination; Humans; Male; Omeprazole; Pentagastrin; Secretory Rate | 1983 |
Cimetidine and omeprazole accelerate gastric ulcer healing by an increase in gastrin secretion.
Topics: Analysis of Variance; Animals; Cimetidine; Disease Models, Animal; Drug Interactions; Drug Synergism; Eating; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Male; Omeprazole; Oxidopamine; Pentagastrin; Pyloric Antrum; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Wound Healing | 1994 |
Hydrogen ion concentration in the mucus layer on top of acid-stimulated and -inhibited rat gastric mucosa.
Topics: Animals; Biological Transport; Congo Red; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Male; Microelectrodes; Omeprazole; Pentagastrin; Rats; Rats, Sprague-Dawley | 1994 |
Pathways mediating pentagastrin-induced mucosal blood flow response in rat stomachs.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Interactions; Gastric Acid; Gastric Mucosa; Glycine; Indomethacin; Male; Omeprazole; Pentagastrin; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Theophylline | 1996 |
Effect of omeprazole on sodium and potassium output in pentagastrin-stimulated equine gastric contents.
Topics: Animals; Anti-Ulcer Agents; Female; Gastric Juice; Gastric Mucosa; Horses; Male; Omeprazole; Pentagastrin; Potassium; Sodium; Stomach | 1996 |
Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma.
Topics: Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Follow-Up Studies; Gastrins; Humans; Immunoradiometric Assay; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Omeprazole; Pentagastrin; Reference Values; Thyroid Neoplasms | 1997 |
Omeprazole induces high intraglandular pressure in the rat gastric mucosa.
Topics: Animals; Anti-Ulcer Agents; Gastric Mucosa; Injections, Intravenous; Intubation, Gastrointestinal; Male; Mucus; Omeprazole; Pentagastrin; Pharmaceutical Vehicles; Pressure; Rats; Rats, Inbred Lew; Rats, Inbred Strains | 1997 |
Nitric oxide, prostaglandin, and sensory neurons in gastric mucosal blood flow response during acid secretion in rats.
Topics: Animals; Capsaicin; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Indomethacin; Male; Neurons, Afferent; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Omeprazole; Pentagastrin; Prostaglandins; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley | 1997 |
Effect of inhibition of pentagastrin-stimulated acid secretion on gastric mucosal gland luminal pressure.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Hydrostatic Pressure; Omeprazole; Pentagastrin; Ranitidine; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley | 1997 |
Noninvasive assessment of gastric acid secretion in man. Application of electrical impedance tomography (EIT).
Topics: Adolescent; Adult; Anti-Ulcer Agents; Electric Impedance; Gastric Acid; Humans; Omeprazole; Pentagastrin; Predictive Value of Tests; Reference Values; Sensitivity and Specificity; Tomography | 1997 |
Active immunization against somatostatin alters regulation of gastrin in response to gastric acid secretagogues.
Topics: Animals; Anti-Ulcer Agents; Catheters, Indwelling; Drug Combinations; Female; Gastric Acid; Gastrins; Histamine; Hydrochloric Acid; Immunization; Male; Omeprazole; Pentagastrin; Sheep; Somatostatin | 1998 |
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastric Acid; Gastric Mucosa; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Male; Omeprazole; Pentagastrin; Perfusion; Pyrilamine; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1998 |
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |
Developmental regulation of gastric somatostatin secretion in the sheep.
Topics: Aging; Animals; Animals, Newborn; Drug Combinations; Embryonic and Fetal Development; Female; Fetus; Gastric Mucosa; Gastrins; Histamine; Male; Omeprazole; Pentagastrin; Ranitidine; Sheep; Somatostatin; Stomach; Time Factors | 1999 |
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Calcium; Cats; Chronic Disease; Cysteamine; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Gastric Fistula; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Perfusion; Phenylurea Compounds; Rabbits; Ranitidine; Rats; Receptors, Cholecystokinin; Stomach; Stomach Ulcer | 1999 |
Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Female; Gastric Acidity Determination; Gastric Juice; Horse Diseases; Horses; Hydrogen-Ion Concentration; Omeprazole; Pentagastrin; Pharmaceutical Vehicles; Reference Values; Stomach Diseases; Tablets, Enteric-Coated | 1999 |
Acid secretion and response to pentagastrin or omeprazole in human fetal stomach xenografts.
Topics: Animals; Fetal Tissue Transplantation; Gastric Acid; Humans; Mice; Mice, Nude; Omeprazole; Pentagastrin; Stomach; Transplantation, Heterologous | 2000 |
Acid transport through channels in the mucous layer of rat stomach.
Topics: Animals; Biological Transport; Coloring Agents; Congo Red; Gastric Acid; Gastric Mucosa; Hybridization, Genetic; Male; Mucus; Omeprazole; Pentagastrin; Rats; Rats, Inbred Strains | 2000 |
Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aminopyrine; Animals; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Histamine; In Vitro Techniques; Male; Omeprazole; Pentagastrin; Proton Pump Inhibitors; Rabbits; Rats; Rats, Sprague-Dawley; Stomach; Sulfoxides | 2001 |
Intragastric pH regulates conversion from net acid to net alkaline secretion by the rat stomach.
Topics: Alkalies; Animals; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Male; Omeprazole; Pentagastrin; Perfusion; Rats; Rats, Sprague-Dawley; Somatostatin; Stomach | 2001 |
Very early detection of RET proto-oncogene mutation is crucial for preventive thyroidectomy in multiple endocrine neoplasia type 2 children: presence of C-cell malignant disease in asymptomatic carriers.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Catecholamines; Child; Child, Preschool; DNA Mutational Analysis; DNA Primers; DNA, Neoplasm; Drosophila Proteins; Female; Germ-Line Mutation; Humans; Hyperplasia; Infant; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Omeprazole; Pentagastrin; Polymerase Chain Reaction; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy | 2002 |
Coordinated regulation of gastric chloride secretion with both acid and alkali secretion.
Topics: Alkalies; Animals; Chlorides; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Male; Omeprazole; Pentagastrin; Rats; Rats, Sprague-Dawley; Stomach | 2002 |
Rebound acid hypersecretion after long-term inhibition of gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Enterochromaffin-like Cells; Esophagitis; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Immunohistochemistry; Lansoprazole; Long-Term Care; Male; Middle Aged; Omeprazole; Pentagastrin; Proton Pump Inhibitors | 2005 |
Validation of a conscious rat model for the discovery of novel agents that inhibit gastric acid secretion.
Topics: Administration, Oral; Animals; Cimetidine; Consciousness; Dimaprit; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrointestinal Agents; Histamine H2 Antagonists; Imidazoles; Ligation; Male; Models, Animal; Omeprazole; Pentagastrin; Proton Pump Inhibitors; Pyridines; Rats; Rats, Wistar; Reproducibility of Results; Stomach; Suction | 2008 |
Inhibition of H+/K+ ATPase in the gastroprotective effect of Baccharis illinita DC.
Topics: Animals; Atropine; Baccharis; Bethanechol; Dose-Response Relationship, Drug; Female; Flowers; Gastric Acid; Gastric Acidity Determination; H(+)-K(+)-Exchanging ATPase; Histamine; Luteolin; Omeprazole; Pentagastrin; Plant Extracts; Proton Pump Inhibitors; Rats; Rats, Wistar; Stomach | 2008 |
Modification of gastric pH in the fasted dog.
Topics: Animals; Buffers; Dogs; Fasting; Gastric Emptying; Glycine; Hydrochloric Acid; Hydrogen-Ion Concentration; Injections, Intravenous; Jejunum; Male; Models, Animal; Omeprazole; Pentagastrin; Potassium Chloride; Ranitidine; Stomach; Time Factors | 2010 |
Calcium [¹³C]carbonate breath test for quantitative measurement of total gastric acid in rats.
Topics: Animals; Breath Tests; Calcium Carbonate; Carbon Dioxide; Carbon Isotopes; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Hydrogen-Ion Concentration; Omeprazole; Pentagastrin; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium Bicarbonate | 2012 |
The cholecystokinin CCK2 receptor antagonist, JNJ-26070109, inhibits gastric acid secretion and prevents omeprazole-induced acid rebound in the rat.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastrins; Histamine; Male; Omeprazole; Pentagastrin; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Sulfonamides | 2012 |